Julie Zarraga - Feb 8, 2023 Form 4 Insider Report for LanzaTech Global, Inc. (LNZA)

Signature
/s/ Joseph Blasko, as Attorney-in-Fact
Stock symbol
LNZA
Transactions as of
Feb 8, 2023
Transactions value $
$0
Form type
4
Date filed
2/10/2023, 08:36 PM
Next filing
May 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LNZA Stock Options Award +20K 20K Feb 8, 2023 Common Stock 87.5K $1.52 Direct F1, F3
transaction LNZA Stock Options Award +20K 20K Feb 8, 2023 Common Stock 87.5K $1.52 Direct F1, F3
transaction LNZA Stock Options Award +20K 20K Feb 8, 2023 Common Stock 87.5K $1.38 Direct F1, F3
transaction LNZA Stock Options Award +30K 30K Feb 8, 2023 Common Stock 131K $1.07 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options are fully vested and exercisable.
F2 60% of the options are vested and exercisable, 20% vests on each of January 1, 2024 and January 1, 2025.
F3 On February 8, 2023, AMCI Acquisition Corp. II ("AMCI") consummated a business combination (the "Business Combination") by and among AMCI, AMCI Merger Sub, Inc., a Delaware corporation ("AMCI Merger Sub") and LanzaTech NZ, Inc., a Delaware corporation ("Legacy LanzaTech"), AMCI changed its name to "LanzaTech Global, Inc." and AMCI Merger Sub merged with and into Legacy LanzaTech. As part of the Business Combination, each Legacy LanzaTech stock option was exchanged for a stock option to acquire 4.374677 shares of common stock of LanzaTech Global, Inc.